Description
KLOW is a compounded blend typically combining KPV (Lys‑Pro‑Val, a melanocortin‑derived tripeptide), GHK‑Cu (copper tripeptide‑1), TB‑500 (a thymosin‑β4 analogue), and BPC‑157 (a gastric‑derived peptide fragment). It’s marketed for tissue support, skin calm, and post‑procedure or training recovery. None of these are FDA‑approved as systemic drugs. TB‑500 and BPC‑157 are prohibited in tested sport. Product identity and quality may vary.






There are no reviews yet.